信必可都保对支气管扩张患者肺功能及炎症反应的影响

doi:10.3969/j.issn.1001-8131.2025.05.002

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (412 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨信必可都保对支气管扩张（BE）患者肺功能及炎症反应的影响。方法采用数字表达随机将我院收治的BE患者80例分成两组,各40例。对照组予基础对症支持治疗,基于此,研究组加用信必可都保,治疗4周,比较两组疗效、肺功能、血气分析指标、炎症反应、生活质量。结果研究组有效率、FEV₁、MVV、FVC、SaO₂与PaO₂均高于对照组（P<0.05）,PaCO₂、IL-8、CRP、TNF-α、SGRQ评分均低于对照组（P<0.05）。结论信必可都保用于BE治疗中疗效确切,能减轻炎性反应,改善肺功能及血气指标,提高生活质量。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	张振西
	黄山

关键词 ：支气管扩张, 信必可都保, 肺功能, 炎症反应

Abstract：Objective To explore the effects of Xinbikeduobao on lung function and inflammatory response in patients with bronchiectasis(BE). Methods 80 BE patients admitted to our hospital were randomly divided into two groups using numerical expression,with 40 patients in each group.The control group received basic symptomatic supportive treatment,and based on this,the study group received additional treatment with Xinbikeduobao for 4 weeks.The efficacy,lung function,blood gas analysis indicators,inflammatory response,and quality of life were compared between the two groups. Results showed that the effective rate,FEV₁,MVV,FVC,SaO₂,and PaO₂ of the study group were higher than those of the control group(P<0.05),while the PaCO₂,IL-8,CRP,TNF-α,and SGRQ scores were lower than those of the control group(P<0.05). Conclusion Xinbikeduobao has a definite therapeutic effect in the treatment of BE,which can reduce inflammatory reactions,improve lung function and blood gas indicators,and enhance quality of life.

Key words： Bronchiectasis Trustworthy can be guaranteed Pulmonary function inflammatory reaction

收稿日期: 2025-05-26

PACS:

R562.2

引用本文:

张振西, 黄山. 信必可都保对支气管扩张患者肺功能及炎症反应的影响[J]. 哈尔滨医药, 2025, 45(5): 6-8.
Zhang Zhenxi, Huang Shan. The Effect of Xinbikeduobao on Lung Function and Inflammatory Response in Patients with Bronchiectasis. journal1, 2025, 45(5): 6-8.

链接本文:

http://www.hrbyybjb.org.cn/CN/10.3969/j.issn.1001-8131.2025.05.002 或 http://www.hrbyybjb.org.cn/CN/Y2025/V45/I5/6

[1] erpstra LC,van der Geest D,Bronsveld I,ea tl.Treatment with inhaled antibiotics in bronchiectasis,side effects,and evaluation of the tolerance test;analysis from the BATTLE randomized controlled trial[J].Clin Respir J.2023,17(8):748-753.
[2] 钱宇杰,蒋胜利,李波,等.加味桔梗汤加减治疗稳定期支气管扩张患者的效果及对支气管肺泡灌洗液炎症细胞和炎症因子的影响[J].广西医学,2022,44(4):385-388,393.
[3] 张慧娟,韩秀迪,刘学东.长期应用抗生素在支气管扩张症中的有效性和安全性研究进展[J].国际呼吸杂志,2021,41(20):1597-1600.
[4] 栗娜,王海山,韩巧玲,等.思力华联合信必可都保治疗支气管哮喘伴慢阻肺的疗效及对IL-6、CRP水平的影响[J].湖南师范大学学报(医学版),2020,17(2):30-33.
[5] 世界中医药学会联合会呼吸病专业委员会.支气管扩张症中西医结合诊疗专家共识[J].中医杂志,2022,63(22):2196-2200.
[6] Akiki Z,Hallit S,Layoun N,ea tl.Validation of the St George's respiratory questionnaire and risks factors affecting the quality of life of Lebanese COPD and asthma patients[J].J Asthma.2019,56(11):1212-1221.
[7] 刘学东,赵伟业,张淑立,等.成人支气管扩张症的研究进展[J].中华结核和呼吸杂志,2020,43(10):902-905.
[8] Singh D,Brightling C.Bronchiectasis,the Latest Eosinophilic Airway Disease:What About the Microbiome[J].Am J Respir Crit Care Med.2022,205(8):860-862.
[9] 李志成,王丽彦,刘瑶,等.清金化痰汤联合西医常规疗法治疗支气管扩张症急性加重期临床研究[J].国际中医中药杂志,2020,42(6):547-551.
[10] 孙锦贤,余静珠,屠春林,等.桔芩汤对痰热壅肺型支气管扩张患者的血清促炎因子、氧自由基及肺功能的影响[J].实用临床医药杂志,2020,24(7):23-26.
[11] 刘洁静,冯京帅,李霞,等.清肺化痰汤合千金苇茎汤加减对支气管扩张患者FEV₁、FVC及PEF水平的影响[J].陕西中医,2020,41(9):1221-1224.
[12] 陈翠林,冯军军.大剂量布地奈德对哮喘急性发作患儿哮喘症状控制时间及肺功能的影响[J].中国药物与临床,2020,20(17):2937-2939.
[13] 李双双,刘晖,王晶,等.布地奈德/福莫特罗维持和缓解方案对哮喘患者的疗效[J].中国医药. 2021,16(1):55-58.
[14] 罗志兵,刘庆华.不同药物吸入方案对COPD并支气管扩张症效果[J].青岛大学学报(医学版),2022,58(1):123-126.
[15] 张琼. 布地奈德福莫特罗粉吸入剂在稳定期慢性阻塞性肺疾病的临床观察[J].中国药物与临床,2016,16(5):735-737.